<h4>Objective</h4>To evaluate the prevalence of alpha-1 antitrypsin (AAT) variants through SERPINA1 genotyping in patients with non-cystic fibrosis bronchiectasis, and assess their clinical, functional and radiological characteristics. This evidence concerns the gene SERPINA1 and bronchiectasis.